Surgery combined with adenoviral p53 gene therapy for treatment of non-small cell lung cancer: a phase II study

OBJECTIVE: To assess the efficacy of radical surgery combined with recombinant adenoviral human p53 (rAd-p53) gene therapy in treatment of resectable non-small cell lung cancer. METHOD: A total of 163 patients with resectable NSCLC meeting the inclusion criteria were randomly assigned to two groups:...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Bo, Sun, Tianyu, Tang, Bo, Tao, Shaolin, Kang, Poming, Qian, Kai, Jiang, Bin, Li, Kun, Li, Kunkun, Zhou, Jinghai, Wang, Ruwen, Tan, Qunyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739798/
https://www.ncbi.nlm.nih.gov/pubmed/29291013
http://dx.doi.org/10.18632/oncotarget.22333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739798/
https://www.ncbi.nlm.nih.gov/pubmed/29291013
http://dx.doi.org/10.18632/oncotarget.22333

Ejemplares similares